229 Results for "

Cannabinoid Receptor

" in MedChemExpress (MCE) Product Catalog:
Products (229)

229 Results for "Cannabinoid Receptor" in MCE Product Catalog:

Cat. No.: HY-110014
CAS No.: 222723-55-9
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

Noladin ether is a potent and selective agonist of cannabinoid CB1 receptor, with a Ki of 21.2 nM. Noladin ether can cause hypothermia, intestinal immobility, and mild antinociception .
loading...
    loading...
Cat. No.: HY-14753
CAS No.: 861151-12-4
Rosonabant is a selective antagonist for cannabinoid receptor (CB1 receptor), which reduces body weight and improves improves the risk of obesity-related cardiovascular metabolic diseases. Rosonabant exhibits adverse side effect, such as nausea and mental disorder .
loading...
    loading...
Cat. No.: HY-110065
CAS No.: 1048038-90-9
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

SER-601 is a potent and selective peripheral cannabinoid (CB2) receptor agonist with a Ki of 6.3 nM. SER-601 has analgesic and antidiabetic properties and can be used for relevant research .
loading...
    loading...
Cat. No.: HY-110194
CAS No.: 1415264-56-0
Virodhamine TFA is an endocannabinoid, it regulates neurotransmission by activating the cannabinoid (CB) receptors. Virodhamine is an antagonist of CB1 receptor and an agonist of CB2 receptor. Virodhamine TFA induces megakaryocytic differentiation by triggering MAPK signaling and ROS production. Virodhamine TFA can be used for the research of various neurological disorders such as Alzheimer's and Parkinson's diseases .
loading...
    loading...
Cat. No.: HY-128040
CAS No.: 443129-35-9
Virodhamine (hydrochloride) is a cannabinoid CB1 receptor partial agonist and cannabinoid CB2 receptor full agonist .
loading...
    loading...
Cat. No.: HY-133533
CAS No.: 1883545-42-3
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

O-2050 is a high affinity cannabinoid CB1 receptor antagonist with a Ki of 2.5 nM. O-2050 inhibits cannabinoid CB2 receptor (Ki=0.2 nM). O-2050 can cause locomotor stimulation in mice .
loading...
    loading...
Cat. No.: HY-N6097
CAS No.: 88360-87-6
Amauromine is a peripheral selective cannabinoid receptor type 1 (CB1) receptor antagonist with Ki and Kb values of 178 nM and 66.6 nM, respectively .
loading...
    loading...
Cat. No.: HY-105238
CAS No.: 947696-17-5
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

JHU-75528 is a novel ligand of the cannabinoid receptor (CB1). JHU-75528 can be used in the research of imaging CB1 receptor .
loading...
    loading...
Cat. No.: HY-150067
CAS No.: 334668-69-8
Purity:  99.89%
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

CB1R Allosteric modulator 5, a selective cannabinoid-1 receptor (CB1R) inverse agonist with an IC50 value of 4.2 μM and EC50 value of >10 μM. CB1R Allosteric modulator 5 can be used for the research of metabolic and obesity .
loading...
    loading...
Cat. No.: HY-173083
CAS No.: 1103840-28-3
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

MDA7 is the selective agonist for cannabinoid receptor 2 with EC50 of 128 nM and 67.4 nM in human CB2 receptor and rat CB2 receptor. MDA7 exhibits good affinity to human CB2 receptor and rat CB2 receptor with Ki of 422 nM and 238 nM. MDA7 exhibits analgesic activity in rats models .
loading...
    loading...
Cat. No.: HY-114880
CAS No.: 1185282-19-2
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

AB-FUBINACA 3-fluorobenzyl isomer is a synthetic cannabinoid that belongs to the indole derivatives and has a high affinity for the central CB1 receptors (Ki= 0.9 nM), exhibiting anticonvulsant activity .
loading...
    loading...
Cat. No.: HY-100778
CAS No.: 1054451-07-8
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

SMM-189 is  a potent and selective cannabinoid receptor 2 (CB2) inverse agonist. SMM-189 plays an important role in neurodegenerative disorders and traumatic brain injury research .
loading...
    loading...
Cat. No.: HY-W751734
CAS No.: 1220887-84-2
HU 433 is a synthetic cannabinoid CB2 receptor agonist and is the enantiomer of HU 308 (HY-161510). HU 433 exerts its anti-inflammatory and neuroprotective effects by binding to CB2 receptors. HU 433 can be used in the study of neuroinflammation and retinal diseases .
loading...
    loading...
Cat. No.: HY-122281
CAS No.: 194358-72-0
Target:  

Cannabinoid Receptor

Research Areas:  

Others

JTE 7-31 selectively acts on peripheral cannabinoid receptors, minimizing central nervous system side effects. They exhibit potent immunomodulatory, anti-inflammatory and anti-allergic properties, as well as inhibitory effects on nephritis .
loading...
    loading...
Cat. No.: HY-134110
CAS No.: 156910-29-1
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

Anandamide (AEA) is an endogenous cannabinoid that binds to both central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. The biological actions of AEA are terminated by cellular uptake and hydrolysis of the amide bond by the enzyme fatty acid amide hydrolase. Arachidonoyl-N-methyl amide is an analog of anandamide that binds to the human central cannabinoid (CB1) receptor with a Ki of 60 nM. It inhibits rat glial gap junction cell-cell communication 100% at a concentration of 50 μM.
loading...
    loading...
Cat. No.: HY-P1397
CAS No.: 1193362-76-3
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

RVD-Hpα, an α-hemoglobin-derived peptide containing three additional amino acids, is a CB1 cannabinoid receptor agonist. RVD-Hpα is a positive allosteric modulator of cannabinoid receptor 2 .
loading...
    loading...
Cat. No.: HY-134055
CAS No.: 45280-17-9
Synonyms: Arachidonic acid-N,N-dimethyl amide
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

Anandamide (AEA) is an endogenous cannabinoid that binds to both central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. The biological actions of AEA are terminated by cellular uptake and hydrolysis of the amide bond by the enzyme fatty acid amide hydrolase. Arachidonoyl-N,N-dimethyl amide is an analog of anandamide that exhibits weak or no binding to the human central cannabinoid (CB1) receptor (Ki >1 μM). It inhibits rat glial gap junction cell-cell communication 100% at a concentration of 50 μM.
loading...
    loading...
Cat. No.: HY-123594
CAS No.: 157182-47-3
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

R-2 Methanandamide (Compound 2) is a cannabinoid Anandamide (HY-10863) analog with a Ki of 119 nM for the cannabinoid receptor (Ki is determined using rat brain membranes with PMSF) .
loading...
    loading...
Cat. No.: HY-103330
CAS No.: 656804-72-7
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

TC-C 14G (Compd 14g) is a Cannabinoid-1 Receptor (CB1R) inverse agonist, with a Ki of 4 nM and EC50 of 11 nM for HCB1R, respectively .
loading...
    loading...
Cat. No.: HY-152270
CAS No.: 19825-63-9
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

Pirnabine is a cannabinoid receptor ligand. Pirnabine can be used for the research of glaucoma .
loading...
    loading...